Also trades as: 0KHE.L (LSE) · $vol 0M
RVTY NYSE
Revvity, Inc.
1W: +0.3%
1M: +15.7%
3M: +34.2%
YTD: +54.5%
1Y: +65.3%
3Y: +39.8%
5Y: -16.3%
$151.53
+2.47 (+1.66%)
Weekly Expected Move ±6.8%
$131
$141
$152
$162
$172
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
16 relationships15
As Filer
counterparties named
1
As Counterparty
mentioned by others
4
Rel. Types
2021-08-12
Earliest Filing
2025-03-13
Latest Filing
partner: 8
target: 4
acquirer: 2
investor: 1
Counterparties (Filed by RVTY)
15 relationshipsCompanies named in RVTY's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| JPMorgan Chase Bank, N.A. | VYLD | partner | Joint Lead Arranger and Joint Bookrunner | 2025-01-07 | View |
| Goldman Sachs Bank USA | GSCE | partner | Joint Lead Arranger and Joint Bookrunner | 2025-01-07 | View |
| PNC Capital Markets LLC | — | partner | Joint Lead Arranger and Joint Bookrunner | 2025-01-07 | View |
| PerkinElmer U.S. LLC | — | partner | Wholly-owned indirect subsidiary of PerkinElmer, Inc. involved in the asset sale transaction. | 2023-03-16 | View |
| PerkinElmer Topco, L.P. | — | acquirer | Delaware limited partnership (formerly Polaris Purchaser, L.P.) that acquired PerkinElmer's Applied, Food and Enterprise | 2023-03-16 | View |
| Polaris Purchaser, L.P. | PII | acquirer | Acquired Applied, Food and Enterprise Services businesses for up to $2.45 billion | 2022-08-05 | View |
| New Mountain Capital L.L.C. | — | investor | Sponsor managing funds that own the Purchaser | 2022-08-05 | View |
| BioLegend, Inc. | — | target | Target company acquired by PerkinElmer, Inc. in a merger completed on September 17, 2021. | 2021-11-04 | View |
| BioLegend, Inc. | — | target | Target company acquired by PerkinElmer, Inc. in a merger completed on September 17, 2021. | 2021-09-21 | View |
| PerkinElmer Health Sciences, Inc. | — | partner | Borrower under the Revolving Credit Agreement. | 2021-09-21 | View |
| PerkinElmer Life Sciences International Holdings | — | partner | Borrower under the Revolving Credit Agreement. | 2021-09-21 | View |
| PerkinElmer Global Holdings S.à r.l. | — | partner | Borrower under the Revolving Credit Agreement. | 2021-09-21 | View |
| PerkinElmer Health Sciences B.V. | — | partner | Borrower under the Revolving Credit Agreement. | 2021-09-21 | View |
| BioLegend, Inc. | — | target | Target company of the acquisition for which the Notes proceeds are intended | 2021-09-10 | View |
| BioLegend, Inc. | — | target | Target company in the acquisition funded by the credit facility | 2021-08-12 | View |
Mentioned As Counterparty
1 mentionsOther companies that named RVTY in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-04 | Earnings Release; Other Events; Exhibits | View | |
| 2026-05-05 | Earnings Release; Other Events; Exhibits | View | |
| 2026-05-01 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-02-02 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure | View | |
| 2025-10-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-24 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-07-28 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-28 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-25 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde | View | |
| 2025-01-31 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure | View | |
| 2025-01-07 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2024-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-07-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-04-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-04-24 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-02-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-01-09 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2023-10-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR